Results 151 to 160 of about 1,215,470 (219)

The TNFR superfamily member Fn14 impacts immunity and survival in experimental gliomas and response to immune checkpoint inhibitor therapy in glioblastoma patients. [PDF]

Neurooncol Adv
Kanvinde PP, Malla AP, Seas AA, McFarland E, Fang JR, Flick MJ, Connolly NP, Beniwal A, Sharifai N, Chen C, Yepes M, Bar EE, Anastasiadis P, Tran NL, Winkles JA, Woodworth GF.   +15 more
europepmc   +1 more source

Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative

Clinical Pharmacology &Therapeutics, EarlyView.
The U.S. Food and Drug Administration (FDA) used an Active Postmarket Risk Identification and Analysis (ARIA) system to address a safety issue (serious infection) identified during clinical review of an application to market ustekinumab as a treatment for Crohn's disease (CD). FDA used an active‐comparator new‐user cohort design, data from six Sentinel
Joel L. Weissfeld, Geetha S. Iyer, Suna C. Seo, Andrew Giffin, Andrew L. Simon, Sheryl A. Kluberg, Emma R. Hoffman, Jamal T. Jones, Sarah K. Dutcher, Joyce A. Korvick   +9 more
wiley   +1 more source

Accelerating Generic Long‐Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to Access

Clinical Pharmacology &Therapeutics, EarlyView.
The global HIV response aims for widespread availability of affordable, quality‐assured long‐acting antiretroviral (LA ARV) drugs to achieve sustained epidemic control, particularly in low‐ and middle‐income countries. This report summarizes key discussion points, findings, and outcomes from an international workshop on generic LA ARVs, held in ...
Usman Arshad, Lobna Gaayeb, Henry Pertinez, Rajith K. R. Rajoli, Melynda Watkins, Parag Nimbolkar, Simone Perazzolo, Bharat Pagi, Annemarie Wensing, Saye Khoo, Marta Boffito, René Holm, Zack Panos, Imelda Mahaka, Francois Venter, Benny Kottiri, Keith W. Crawford, Rodney J. Y. Ho, Polly Clayden, Paul Domanico, Kimberly Struble, Andrew Owen, Charles Flexner   +22 more
wiley   +1 more source

Maryland\u27s Wetlands: the Legal Quagmire [PDF]

, 1970
Salsbury, Stuart Marshall
core   +1 more source

Dr. Sara E. Monaco: A Mentor Extraordinaire Who Changed Cytopathology in Rural Pennsylvania by “Making It the Best”

Diagnostic Cytopathology, EarlyView.
ABSTRACT This report introduces Dr. Sara E. Monaco, the incoming President‐Elect of the American Society of Cytopathology (ASC) and System Director of Cytopathology at Geisinger Medical Center. Dr. Monaco has provided significant mentorship to me over the years and facilitated the development of my passion for cytopathology and education.
Terrance J. Lynn
wiley   +1 more source

Clinician Perspectives on the Development of a Survivorship Care Plan Smartphone Application: A Qualitative Thematic Analysis. [PDF]

Oncol Nurs Forum
Rangwala M, Baafi Oduro E, McGeorge NM, Deighton D, Kleckner I, Renn CL, Kleckner A.   +6 more
europepmc   +1 more source

Steroidogenic Factor 1 (SF1) Immunohistochemical Stain Is Sensitive and Specific for the Cytopathologic Identification of Intrapancreatic Ectopic Splenic Tissue

Diagnostic Cytopathology, EarlyView.
ABSTRACT Background Accessory spleens result from failure of splenic fusion during development and are occasionally located in the pancreatic tail, radiographically appearing as solid or solid/cystic lesions. Fine needle aspiration (FNA) easily identifies accessory spleens in most samples based on architecture and using CD8 to highlight splenic ...
Adeyinka Akinsanya, Jessica L. Muldoon, Mohamed Mustafa, Bin Yang, Hector Mesa, Omer Saeed   +5 more
wiley   +1 more source

Diagnostic Utility of Ki‐67 Index on Cell Block Material for Grading Medullary Thyroid Carcinoma

Diagnostic Cytopathology, EarlyView.
ABSTRACT Introduction An international grading system for medullary thyroid carcinoma (IMTCGS) was established in 2022. High‐grade MTC is defined by the presence of one or more of the following features: mitotic index ≥ 5 per 2 mm2, Ki‐67 proliferative index ≥ 5%, or tumor necrosis.
Tieying Hou, Hector Mesa, Bianca Puello, Brent Molden   +3 more
wiley   +1 more source

RORγt‐APCs: The New Masters of Oral Tolerance

Barrier Immunity, EarlyView.
ABSTRACT Oral tolerance is defined by the hypo‐responsiveness of our body to fed antigens, and its failure can lead to immune‐mediated diseases, such as allergy, chronic inflammation and autoimmune diseases. Decades of research have demonstrated that antigen‐presenting cells (APCs) promote oral tolerance by inducing regulatory T cells (Tregs) and/or ...
Thierry Gauthier, WanJun Chen
wiley   +1 more source